Treatment with interferon-α for metastatic renal cell cancer

Y. Shirasaki; T. Tsushima; T. Kurashige; N. Kusaka; R. Arata; H. Kaku; T. Saika; Y. Nasu; H. Kumon

Treatment with interferon-α for metastatic renal cell cancer

Y. Shirasaki, T. Tsushima, T. Kurashige, N. Kusaka, R. Arata, H. Kaku, T. Saika, Y. Nasu, H. Kumon

Research output: Contribution to journal › Article › peer-review

Abstract

We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8%. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7%, 21.5% and 12.5%, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.

Original language	English
Pages (from-to)	344-346
Number of pages	3
Journal	Nishinihon Journal of Urology
Volume	63
Issue number	5
Publication status	Published - 2001

Keywords

Interferon
Renal cell cancer

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{dc0908af5a0848a98e1cfd8559eb02f3,

title = "Treatment with interferon-α for metastatic renal cell cancer",

abstract = "We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8%. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7%, 21.5% and 12.5%, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.",

keywords = "Interferon, Renal cell cancer",

author = "Y. Shirasaki and T. Tsushima and T. Kurashige and N. Kusaka and R. Arata and H. Kaku and T. Saika and Y. Nasu and H. Kumon",

year = "2001",

language = "English",

volume = "63",

pages = "344--346",

journal = "Nishinihon Journal of Urology",

issn = "0029-0726",

publisher = "Kyushu University, Faculty of Science",

number = "5",

}

TY - JOUR

T1 - Treatment with interferon-α for metastatic renal cell cancer

AU - Shirasaki, Y.

AU - Tsushima, T.

AU - Kurashige, T.

AU - Kusaka, N.

AU - Arata, R.

AU - Kaku, H.

AU - Saika, T.

AU - Nasu, Y.

AU - Kumon, H.

PY - 2001

Y1 - 2001

N2 - We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8%. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7%, 21.5% and 12.5%, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.

AB - We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8%. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7%, 21.5% and 12.5%, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.

KW - Interferon

KW - Renal cell cancer

UR - http://www.scopus.com/inward/record.url?scp=0035006030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035006030&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035006030

SN - 0029-0726

VL - 63

SP - 344

EP - 346

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

IS - 5

ER -

Treatment with interferon-α for metastatic renal cell cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this